Novoray Crecimiento futuro

Future controles de criterios 5/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Novoray de 27.3% y 22.7% por año respectivamente. Se prevé que el BPA crezca en un 27% al año. Se espera que la rentabilidad financiera sea de 19.6% en 3 años.

Información clave

27.3%

Tasa de crecimiento de los beneficios

27.0%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals	39.5%
Tasa de crecimiento de los ingresos	22.7%
Rentabilidad financiera futura	19.6%
Cobertura de analistas	Low
Última actualización	23 Oct 2024

Actualizaciones recientes sobre el crecimiento futuro

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28

Recent updates

Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

Oct 18

These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Oct 16

What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

Sep 26

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Aug 20

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

May 13

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Apr 23

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28

Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

Mar 01

When Should You Buy Novoray Corporation (SHSE:688300)?

Feb 27

Previsiones de crecimiento de beneficios e ingresos

SHSE:688300 - Estimaciones futuras de los analistas y datos financieros pasados (CNY Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	1,461	420	N/A	358	5
12/31/2025	1,182	329	N/A	282	5
12/31/2024	935	245	N/A	176	5
9/30/2024	895	234	167	248	N/A
6/30/2024	841	218	164	236	N/A
3/31/2024	769	197	137	189	N/A
12/31/2023	712	174	194	247	N/A
9/30/2023	685	182	139	203	N/A
6/30/2023	625	169	156	248	N/A
3/31/2023	630	174	130	277	N/A
12/31/2022	662	188	86	241	N/A
9/30/2022	657	175	24	213	N/A
6/30/2022	686	186	-47	161	N/A
3/31/2022	663	179	-64	117	N/A
12/31/2021	625	173	-55	153	N/A
9/30/2021	581	169	-94	117	N/A
6/30/2021	522	147	-42	135	N/A
3/31/2021	473	130	-57	104	N/A
12/31/2020	404	111	-34	90	N/A
9/30/2020	367	92	19	98	N/A
6/30/2020	341	82	29	95	N/A
3/31/2020	321	78	27	100	N/A
12/31/2019	315	75	20	81	N/A
9/30/2019	298	69	43	97	N/A
6/30/2019	292	67	23	70	N/A
3/31/2019	277	60	29	53	N/A
12/31/2018	278	58	30	56	N/A
9/30/2018	264	54	8	34	N/A
6/30/2018	249	50	N/A	12	N/A
3/31/2018	230	46	N/A	9	N/A
12/31/2017	211	42	N/A	6	N/A
9/30/2017	193	41	N/A	17	N/A
6/30/2017	176	39	N/A	27	N/A
3/31/2017	165	36	N/A	22	N/A
12/31/2016	154	33	N/A	18	N/A
9/30/2016	143	27	N/A	N/A	N/A
6/30/2016	132	20	N/A	16	N/A
3/31/2016	127	19	N/A	12	N/A
12/31/2015	122	18	N/A	7	N/A
9/30/2015	121	19	N/A	3	N/A
6/30/2015	132	20	N/A	9	N/A
3/31/2015	131	19	N/A	16	N/A
12/31/2014	125	19	N/A	17	N/A
12/31/2013	120	14	N/A	28	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (27.3% al año) de 688300 es superior a la tasa de ahorro (2.8%).

Beneficios vs. Mercado: Se prevé que los beneficios (27.3% al año) de 688300 crezcan más rápidamente que el mercado CN (26.2% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de 688300 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (22.7% al año) de 688300 crezcan más rápidamente que los del mercado CN (13.8% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos (22.7% al año) de 688300 crezcan más rápidamente que un 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 688300 sea baja dentro de 3 años (19.6%).

Novoray Crecimiento futuro

Future controles de criterios 5/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 18% to CN¥65.00

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Price target decreased to CN¥54.21

Price target increased to CN¥118

Price target increased to CN¥69.68

Analysts lower revenue estimates to CN¥394.0m

Recent updates

Investor sentiment improves as stock rises 16%

Third quarter 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.28 in 3Q 2023)

Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

New minor risk - Share price stability

Novoray Corporation to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 16%

What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

Second quarter 2024 earnings released: EPS: CN¥0.35 (vs CN¥0.23 in 2Q 2023)

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

Price target increased by 18% to CN¥65.00

What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Novoray Corporation to Report First Half, 2024 Results on Aug 26, 2024

Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

Dividend of CN¥0.50 announced

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

First quarter 2024 earnings released: EPS: CN¥0.28 (vs CN¥0.15 in 1Q 2023)

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Novoray Corporation to Report Q1, 2024 Results on Apr 26, 2024

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Novoray Corporation, Annual General Meeting, Apr 19, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

When Should You Buy Novoray Corporation (SHSE:688300)?

Investor sentiment deteriorates as stock falls 16%

New minor risk - Share price stability

Investor sentiment improves as stock rises 23%

Third quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.21 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.26 in 2Q 2022)

Now 21% undervalued

Investor sentiment improves as stock rises 15%

First quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.34 in 1Q 2022)

Investor sentiment improves as stock rises 32%

Investor sentiment improves as stock rises 18%

Full year 2022 earnings released: EPS: CN¥1.51 (vs CN¥1.39 in FY 2021)

Price target decreased to CN¥54.21

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.58 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.49 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Price target increased to CN¥118

Less than half of directors are independent

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.58 (vs CN¥0.33 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.49 (vs CN¥0.29 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Price target increased to CN¥69.68

First quarter 2021 earnings released: EPS CN¥0.43 (vs CN¥0.21 in 1Q 2020)

Investor sentiment improved over the past week

New 90-day low: CN¥40.31

New 90-day low: CN¥40.48

New 90-day low: CN¥47.02

Market pulls back on stock over the past week

New 90-day low: CN¥50.10

Third quarter earnings released

Analysts lower revenue estimates to CN¥394.0m

Novoray Corporation to Report Q3, 2020 Results on Oct 22, 2020

New 90-day low: CN¥51.88

New 90-day low - CN¥53.99

First half earnings released

Novoray Corporation to Report First Half, 2020 Results on Aug 26, 2020

Previsiones de crecimiento de beneficios e ingresos